Bottomline: True North-backed Anthem Bio’s margins shrink again, revenue remains in a spot

Premium

Anthem Biosciences Pvt Ltd had nearly doubled its revenue in FY21, the same year in which it hit a billion-dollar valuation following investment by private equity firm True North. That performance, however, has turned out to be a flash in the pan and the company’s topline has since seen more of a ......